Oesterreich Steffi
Department of Medicine and Molecular and Cellular Biology, The Breast Center, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
J Cell Biochem. 2003 Nov 1;90(4):653-61. doi: 10.1002/jcb.10685.
Scaffold attachment factor B1 (SAFB1) and SAFB2 are large, multifunctional proteins that have been implicated in numerous cellular processes including chromatin organization, transcriptional regulation, RNA splicing, and stress response. While the two homologous proteins show high similarity, and functional domains are highly conserved, evidence suggests that they also have unique properties. For example, SAFB2 can be found in both the nucleus and cytoplasm, whereas SAFB1 seems to be mainly localized in the nucleus. In breast cancer cells, SAFBs function as estrogen receptor corepressors and growth inhibitors. SAFB protein expression is lost in approximately 20% of breast cancers. Interestingly, the two genes reside in close proximity, oriented head-to-head, on chromosome 19p13, a locus which is frequently lost in clinical breast cancer specimens. Furthermore, SAFB1 mutations have been identified in breast tumors that were not present in adjacent normal tissue. The possibility that SAFB1 and SAFB2 are novel breast tumor suppressor genes, and how they might function in this role, are discussed.
支架附着因子B1(SAFB1)和SAFB2是大型多功能蛋白,参与了包括染色质组织、转录调控、RNA剪接和应激反应在内的众多细胞过程。虽然这两种同源蛋白具有高度相似性,且功能域高度保守,但有证据表明它们也具有独特的特性。例如,SAFB2可在细胞核和细胞质中均被发现,而SAFB1似乎主要定位于细胞核。在乳腺癌细胞中,SAFBs作为雌激素受体共抑制因子和生长抑制剂发挥作用。约20%的乳腺癌中SAFB蛋白表达缺失。有趣的是,这两个基因在19号染色体p13区域紧密相邻且头对头排列,该位点在临床乳腺癌标本中经常缺失。此外,在乳腺肿瘤中已鉴定出SAFB1突变,而相邻正常组织中不存在这些突变。本文讨论了SAFB1和SAFB2作为新型乳腺肿瘤抑制基因的可能性,以及它们可能如何发挥这一作用。